Preoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist Device (PROPER-LVAD)
Sponsor: RWTH Aachen University
This PHASE3 trial investigates Cardiac Surgery and End-stage Heart Failure and is currently ongoing. RWTH Aachen University leads this study, which shows 9 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jun 2022 — Jun 2024 [monthly]
Recruiting PHASE3
Status: Unknown Status → Recruiting
-
Apr 2022 — Jun 2022 [monthly]
Unknown Status PHASE3
Status: Not Yet Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Not Yet Recruiting PHASE3
-
Apr 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2020 — Apr 2020 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2020 — Feb 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- RWTH Aachen University
For direct contact, visit the study record on ClinicalTrials.gov .